Energetic Chemistry in Pharma
The Increasing Importance of Manufacturability in API Development
Antibody + Drug + Third Party, Antibody + siRNAASO + Third Party
Redefining RNA Manufacturing Through Innovation in Biocatalysis
Rise of AI ML-Powered Accelerators in Pharma Secure Supply Chain
EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Advancing Biopharmaceutical Innovation Through Cell Encapsulation and Biomimetic Therapeutic Systems
My interest in biopharmaceutical engineering began during my senior year as an undergraduate For my capstone project I worked on the encapsulation of...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Real-World Data and Real-World Evidence: Shaping the Future of Clinical Research
American healthcare generates a staggering volume of patient data every day electronic health records claims pharmacy fills laboratory results registries and increasingly sensor streams Congress recognised the opportunity in directing the FDA through the st Century Cures Act to build
-
Techno Trends
FDA Authorises Aletta for Autonomous Blood Collection
The US Food and Drug Administration FDA has authorised Aletta the first standalone robotic device designed to collect blood from a patients arm without handson operator intervention
-
Projects
Cambrex Expands Milan R&D Operations With US$30 Million Investment
Cambrex has begun construction of a new research and development facility at its Profarmico Milano site in Italy supported by a US million investment The initiative is designed
-
Research Insights
Phycocyanobilin: A potential bioactive compound from Arthrospira platensis targeting LYN protein associated with systemic lupus erythematosus
Phycocyanobilin a bioactive compound derived from Arthrospira platensis C was investigated for its potential role in systemic lupus erythematosus SLE based on its structural similarity to bilirubin
-
White Papers
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys complexity
TOP ARTICLES
-
1
Harnessing Digital Biomarkers and Wearables: Transforming Clinical Research
Kate Williamson
Digital biomarkers and wearables are revolutionizing clinical research by providing real-time data on patients' health. They offer insights into physiological and behavioral changes, and improve t...
-
2
Mass Spectrometry Techniques in Pharmaceutical Analysis: A Pathway to Improved Drug Quality
Kate Williamson
Mass spectrometry (MS) plays a vital role in pharmaceutical analysis, ensuring drug quality, safety, and regulatory compliance. It excels in drug compound identification, quantitative analysis, impuri...
-
3
Microbiome Research: Understanding Its Impact on Drug Metabolism and Health
Sarah Richards
Microbiome research shows that it plays a very important role as a mediator of metabolism and having a strong or bearing on health. Gut bacteria impact drug bioavailability, effectiveness, and side ef...
-
4
Drug Resistance in Bacteria: An Emerging Crisis
Ayush Amod
Sintu Kumar Samanta
Bacterial infections adversely impact global public health. Most bacterial infections in humans are associated with biofilm formation which makes them highly resistant to commercially available antibi...
-
5
eCTD Compliance Guide: Best Practices for Pharmaceutical Regulatory Submissions
Kate Williamson
This guide examines the basics of eCTD compliance, with professional knowledge on the best practice of pharmaceutical regulatory submissions. It emphasizes global standards, lifecycle management, eCTD...
press releasesRead more...
Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development
Psyence Biomedical Ltd Nasdaq PBM Psyence BioMed or the Company a biopharmaceutical company developing naturederived neuroplastogen therapeutics today announced the formation
FDA Approves First Therapy to Target Muscle Loss in Spinal Muscular Atrophy
The US Food and Drug Administration today approved Isembyld apitegromabmstn injection to treat spinal muscular atrophy SMA in adults and pediatric patients years of age and older
Tenaya Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for TN-401 for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
Tenaya Therapeutics Inc NASDAQ TNYA a clinicalstage biotechnology company with a mission to discover develop and deliver potentially curative therapies that address the underlying causes of heart disease
Exegenesis Bio and Modalis Collaborate to Advance MDL-201 for Duchenne Muscular Dystrophy
Exegenesis Bio and Modalis Therapeutics Corporation TOKYO Modalis today announced that they have signed a research collaboration and license agreement to advance MDL
Events Read more...
14 - 16
Sep 202614 - 15
Sep 202616th American DDF Summit
Omni Boston Hotel at the Seapo...
15 - 17
Sep 2026COPD Drug Development Summit 2026
Street, Boston, MA 02210, USA
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality
Illume Hotel Taipei, Taiwan
22 - 24
Sep 2026InsurInnovator Connect Asia
Singapore
28 - 02
Sep 2026Discovery on Target 2026
Boston, MA, USA
LATEST NEWSRead more...
Curium Receives FDA Approval for BEXLUTRY Radioligand Therapy for GEP-NETs
Curium has received approval from the US Food and Drug Administration FDA for BEXLUTRY lutetium Lu dotatate injection to treat adults with somatostatin receptorpositive gastroenteropancreatic neuroendocrine tumours GEPNETs
Aptar Pharma and Massachusetts General Hospital Partner on Nose-to-Brain Drug Delivery Research
Aptar Pharma and Massachusetts General Hospital MGH have entered into a research collaboration to advance nosetobrain NB drug delivery for neurological and central nervous system CNS diseases
ABEC Opens New Manufacturing Facility in North Carolina
ABEC has opened a new manufacturing facility in Wilson North Carolina expanding its global production network and strengthening support for the growing biopharmaceutical industry
Biora Therapeutics to Initiate First Human Study of BioJet Oral Biologic Delivery Capsule
Biora Therapeutics plans to begin its first human clinical study of BioJet an ingestible capsule designed to deliver medicines directly into the small intestine using liquid jet technology
Lotus Neuro launches to advance targeted therapies across the blood-brain barrier
Lotus Neuro a clinicalstage biotechnology company focused on neurological diseases has announced its public launch The company combines focused ultrasound with existing therapeutic approaches to improve the delivery of medicines across the bloodbrain barrier BBB
Sobi receives US FDA Fast Track designation for pacritinib in VEXAS syndrome
Sobi North America the North American affiliate of Swedish Orphan Biovitrum Sobi has announced that the US Food and Drug Administration FDA has granted Fast Track designation to pacritinib for the treatment of VEXAS syndrome
